CFTR and cystic fibrosis: These drugs, such as Ivacaftor, Lumacaftor/Ivacaftor, and the more recent triple-combination therapies like Elexacaftor/Tezacaftor/Ivacaftor (ETI), have revolutionized CF care by targeting the underlying defect in the CFTR protein.